Thierry Aupérin

Thierry Aupérin is an experienced leader in the pharmaceutical industry, currently serving as Vice President of Global Scientific Communications at Alnylam Pharmaceuticals since 2019, where responsibilities include establishing a Medical Communications and Training team and implementing Medical Affairs strategies. Prior roles include Vice President of Medical Affairs at Ohana Biosciences, Executive Director of Global Scientific Communications at Bioverativ, and Director positions at Biogen and Sanofi Genzyme, among others. Aupérin's expertise encompasses medical communications, KOL engagement, strategic planning, and team building across various sectors, especially in rare diseases and hematology. Educational qualifications include a PhD from Harvard Medical School, an MS from the University of Science, and a BS from Pierre and Marie Curie University.